Visiongain will be
holding its 6th Annual Biosimilars Conference on March 2-4, 2010 in Boston,
MA.  At the conference, Visiongain
faculty will offer presentations on the following topics on March 3-4:

• Opportunities and
challenges for biosimilars in the global market;
• Commercializing
biosimilars:  Will they really be
able to compete?
• Demystifying the
market aspects/implications of follow on biologics;
• The impact of a
patient centric viewpoint on biosimilars;
• Strategies for
process development/manufacturing of biosimilars (for global markets);
• Bioassays for
biosimilars;
• Immunogenicity
Programs — Not just another box to check;
• Role of USP
standards in the quality assessment of biological medicines;
• An overview on
regulatory and scientific issues of biosimilars and follow-on biologics;
• Legislative and
regulatory developments impacting the biologics and biosimilars marketplace;
• Trends and
technical challenges for the development of biosimilars in China;
• Follow-on Biologics
(Biosimilars) development with approval and market access;
• Biosimilars —
Succeeding in the market of the future; and
• Clinical Phase 1
PK/PD trials for biosimilar/follow-on products.

In addition, a
pre-conference interactive biosimilars workshop entitled "Creating
confidence in a new wave of biologics therapy — Overcoming barriers to
entry" will be offered on March 2. 
The agenda for the Biosimilars Conference can be found here.  A complete brochure for this
conference, including an agenda, list of speakers, and registration form can be
downloaded here (free
registration required).

The registration
fee ranges from £1299 ($2,099.31)
for the conference alone to
£1699 ($2,745.75) for the conference and workshop; the fee for
attending the workshop alone is £599 ($968.04). Those interested in registering for the
conference can do so here.